Should They Take Both Together or Space Them Out?
You can take lisinopril and trimethoprim-sulfamethoxazole (Bactrim) together at the same time—spacing the doses apart does not reduce the risk of hyperkalemia, which is the primary concern with this combination. The issue is not about timing of administration but about the pharmacologic interaction that occurs regardless of when you take each medication.
The Core Problem: Hyperkalemia Risk
The concern with combining an ACE inhibitor like lisinopril with trimethoprim-sulfamethoxazole is hyperkalemia (elevated potassium levels), not a timing-dependent drug absorption issue. Trimethoprim acts like a potassium-sparing diuretic by blocking sodium channels in the distal nephron, similar to amiloride 1. When combined with ACE inhibitors that also raise potassium by reducing aldosterone, the risk of dangerous hyperkalemia increases substantially.
The evidence is clear and concerning:
- Trimethoprim-sulfamethoxazole increases the risk of hyperkalemia-associated hospitalization nearly 7-fold (adjusted OR 6.7) in elderly patients taking ACE inhibitors or ARBs compared to other antibiotics 2
- This combination is associated with a 2.5-fold increased risk of sudden death (adjusted OR 2.46) when used with spironolactone, another potassium-retaining agent 3
- Even low-dose trimethoprim-sulfamethoxazole carries significant risk, with renal insufficiency plus ACE inhibitor/ARB use being the major risk factor (adjusted OR 3.96) 4
Why Spacing Doesn't Help
Separating the doses by hours does nothing to mitigate this risk because:
- The mechanism is pharmacodynamic (how the drugs affect your body), not pharmacokinetic (how your body absorbs the drugs)
- Both drugs have relatively long half-lives and maintain steady effects throughout the day
- The potassium-retaining effects persist as long as both medications are in your system
- Guidelines specifically identify trimethoprim-sulfamethoxazole as a drug interaction concern with ACE inhibitors but make no mention of dose timing as a mitigation strategy 5, 6, 1
What You Actually Need to Do
Instead of worrying about timing, focus on monitoring and risk assessment:
High-Risk Features (Consider Alternative Antibiotic):
- Creatinine clearance <60 mL/min or eGFR <60 mL/min/1.73 m² 4
- Baseline serum potassium >4.5 mmol/L 5
- Serum creatinine ≥0.78 mg/dL 7
- Diabetes mellitus with any renal impairment 8
- Concurrent use of other potassium-retaining drugs (spironolactone, amiloride, triamterene) 6, 1
- Elderly patients (≥66 years) 2
If You Must Use This Combination:
Check potassium and creatinine within 3-7 days of starting trimethoprim-sulfamethoxazole (the median time to peak potassium elevation is 12 days) 4
Stop trimethoprim-sulfamethoxazole immediately if:
Consider dose reduction: Half-strength dosing (40/200 mg daily instead of 80/400 mg daily) may reduce discontinuation rates while maintaining efficacy, particularly in patients with mild renal impairment 7
Preferred Alternative Antibiotics:
When clinically appropriate, choose antibiotics that don't cause hyperkalemia 2, 3:
- Amoxicillin (no increased hyperkalemia risk)
- Norfloxacin (no increased hyperkalemia risk)
- Avoid ciprofloxacin if possible (modest increased risk, adjusted OR 1.55) 3
Common Pitfall to Avoid
Do not assume that "taking medications at different times" protects you from drug interactions. This misconception applies to absorption interactions (like taking calcium with antibiotics), but the ACE inhibitor + trimethoprim interaction is a systemic pharmacologic effect that persists regardless of dosing schedule. The FDA drug label explicitly lists ACE inhibitors/ARBs as drugs that cause hyperkalemia when combined with trimethoprim-sulfamethoxazole, with no mention of timing strategies 1.
The European Society of Cardiology guidelines specifically warn against the combination of ACE inhibitors with trimethoprim-sulfamethoxazole and recommend close monitoring, not dose separation 6.
Bottom line: Take them together if you must use both, but monitor potassium closely and strongly consider an alternative antibiotic if you have any risk factors for hyperkalemia.